Required Acknowledgement of ConduITS CTSA Support and the NIH Public Access Policy

Jun 1, 2021 | Conduits News

NIH Public Access Policy requires publications, posters, grants arising from research projects receiving support from the ConduITS CTSA to acknowledge grant support.

This is applicable to all faculty and research staff within the MSHS who have received ConduITS support which includes consultations, training, workshops, funding and through the use of ConduITS resources and services, the full list of these and the language to include in your publications can be found on the Research Roadmap under Publications/ NIH Public Access Policy.

NIH Public Access Policy ensures that the public has access to the published results of NIH-funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central (http://www.ncbi.nlm.nih.gov/pmc/). The Policy requires that these final peer-reviewed manuscripts be accessible to the public on PubMed Central to help advance science and improve human health.

Once posted to PubMed Central, results of NIH-funded research become more prominent, integrated and accessible, making it easier for all scientists to pursue NIH’s research priority areas competitively. PubMed Central materials are integrated with large NIH research data bases which helps accelerate scientific discovery. Clinicians, patients, educators, and students can better reap the benefits of papers arising from NIH funding by accessing them on PubMed Central at no charge. Finally, the Policy allows NIH to monitor, mine, and develop its portfolio of taxpayer funded research more effectively, and archive its results in perpetuity. FAQ’s about PubMed Central are available here.

It is important to note that publications that do not comply with this policy and are submitted with a grant may delay or prevent awarding of funds. Compliance with the NIH Public Access Policy is not a factor in the scientific and technical merit evaluation of grant applications. Submission methods can be found here.

For questions or additional information please place a Research 411 help desk ticket with the the Office of Research Services.

Administrators and Investigators can also find instructions on how to monitor compliance for publications here.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

Recent ConduITS News

Introduction to the Research Roadmap

Who Should Use the Research Roadmap at Mount Sinai? Researchers, research teams, and trainees within the Mount Sinai Health System (MSHS), including any research professional at the Icahn School of Medicine at Mount Sinai (ISMMS).  What is the Research Roadmap? The...

read more

Introduction to ResearchMatch

What is ResearchMatch? ResearchMatch is a nonprofit, online recruitment platform designed to connect researchers with volunteers interested in participating in health-related research studies. It allows researchers to efficiently find eligible participants while...

read more

Introduction to Oncore

OnCore is Mount Sinai’s Clinical Trials Management System (CTMS), that is designed to support the full lifecycle of research studies. It helps teams manage protocols, track enrollment and oversee finances —all through integrated tools and automated workflows.  Mount...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more